Opening Keynote

Mar 28, 2017
8:30 AM - 9:00 AM

SETTING THE STAGE: An inside look at recent trends and outcomes in personalized medicine investments and joint ventures, plus a forecast for future innovation and funding in the space

Nick's passion is building companies at the intersection of technology and human health. He is the Founder and Managing Partner of Illumina Ventures, an independently managed venture fund in a strategic partnership with Illumina. Illumina provides the majority of the fund's capital and access to the expertise and vision of the world's leading genomics solutions provider.

The fund invests primarily in early stage companies, in areas where its expertise and special relationship with Illumina can add value. Focus areas include applications of genomics in life science research, healthcare, agriculture and environmental science, public safety, and personal wellness.

Prior to joining Illumina Ventures, Nick served as Senior Vice President, Corporate & Venture Development for Illumina, where he was responsible for strategic planning, business development, licensing, venture investing, and acquisitions. In six years, Nick and his team completed ten acquisitions, more than a dozen venture investments, and a multitude of other transactions, including the formation of Helix and GRAIL and the creation of a global NIPT patent pool.


Nick Naclerio, PhD, Founder and Managing Partner, Illumina Ventures